RxDoctor Payments Data

Jeffrey Rosenbloom, MD

Otolaryngology · San Antonio, TXNPI 1386652378

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,031 of the $22,858 with a category attached, or 65.8%. Acclarent, Inc accounts for 81.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $16,114 and has fallen 95.3% since, to $754 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,858in general payments, 2019–2025

Across 140 payments — averaging $163.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$19K
  • Ambu Inc.$900
  • Optinose US, Inc.$822
  • Regeneron Healthcare Solutions, Inc.$810
  • Medtronic$435
  • Aerin Medical Inc.$291
  • plus $882 from 15 others
$708,229in research payments, 2019–2025

Across 110 payments — averaging $6438.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$235K
  • GSK$184K
  • Aerin Medical Inc.$94K
  • Eli Lilly$66K
  • Intersect ENT, Inc.$56K
  • Hill Dermaceuticals, Inc.$24K
  • plus $47K from 5 others

What the payments were for

  • Consulting fees$15,03166%
  • Speaking & faculty fees$1481%
  • Travel & lodging$3,56416%
  • Food & beverage$4,05018%
  • Education$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,858 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$274,693
Medicare patients
847
Services billed
4,759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole168$2,575
Ipratropium Bromide83$2,433
Azelastine Hcl39$2,198
Famotidine123$1,925
Fluticasone Propionate42$1,171
Ciprofloxacin Hcl80$971
Mometasone Furoate29$703
Amoxicillin49$336
Doxycycline Hyclate25$241
Pantoprazole Sodium12$222
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$90
Methylprednisolone14$87
Levofloxacin15$82
Mupirocin11$61
Prednisone54$61

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →